 | | DRUG: Insulin, isophane | |
| Entry |
|
|---|
| Name |
Insulin, isophane (USP);
Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18);
Isophane insulin (aqueous suspension) (JAN);
Humalog PEN (TN) |
|---|
| Class |
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
|
|---|
| Remark |
| Therapeutic category: | 2492 |
|
|---|
| Efficacy |
Antidiabetic, Insulin receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
CYP induction: CYP1A2 [HSA: 1544]
|
|---|
| Structure map |
|
|---|
| Brite |
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Intermediate-acting
Isophane Insulin, Human
D04547 Insulin, isophane (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D04547 Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
D04547 Insulin, isophane
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D04547 Insulin, isophane
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D04547 Insulin, isophane
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D04547 Insulin, isophane (USP) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D04547 Isophane insulin human (genetical recombination) injectable aqueous suspension
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04547
|
|---|
| Other DBs |
|
|---|
|
» Japanese version » Back
|
|